Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Association of miR-17-92 rs9588884 gene polymorphism with cognitive impairment in depression

by jlohrconsulting | Sep 22, 2025 | Uncategorized

Mol Biol Rep. 2025 Sep 22;52(1):934. doi: 10.1007/s11033-025-11008-x. ABSTRACT BACKGROUND: Depression with cognitive impairment impairs the social and learning abilities of adolescents, causing great trouble in their lives and families. AIM: To investigate the effect...

The Consequence of the Cape: A Mixed-Methods Inquiry into the Sociocultural Stressors Impacting Black Women’s Health

by jlohrconsulting | Sep 22, 2025 | Uncategorized

J Racial Ethn Health Disparities. 2025 Sep 22. doi: 10.1007/s40615-025-02636-x. Online ahead of print. ABSTRACT BACKGROUND: Black women face a disproportionate burden of health issues, including higher rates of aggressive breast cancer and chronic stress-related...

Prevalence and Trajectories of Perinatal Anxiety and Depression in a Large Urban Medical Center

by jlohrconsulting | Sep 22, 2025 | Uncategorized

JAMA Netw Open. 2025 Sep 2;8(9):e2533111. doi: 10.1001/jamanetworkopen.2025.33111. ABSTRACT IMPORTANCE: Perinatal depression and anxiety are common yet underdiagnosed and undertreated. There are limited data on screening rates, severity, and treatment, and thus an...

Efficacy and Safety of Ammoxetine in Major Depressive Disorder: A Randomized Clinical Trial

by jlohrconsulting | Sep 22, 2025 | Uncategorized

JAMA Netw Open. 2025 Sep 2;8(9):e2532650. doi: 10.1001/jamanetworkopen.2025.32650. ABSTRACT IMPORTANCE: Major depressive disorder (MDD) is among the most prevalent mental health disorders, causing substantial disability and economic burden. Although several first-line...

Psychopharmacology Clinical Trial Recruitment Challenges in Neurogenetic Syndromes: Lessons from an Open-Label Trial of Fluoxetine in Down Syndrome

by jlohrconsulting | Sep 22, 2025 | Uncategorized

J Child Adolesc Psychopharmacol. 2025 Sep 22. doi: 10.1177/10445463251379822. Online ahead of print. ABSTRACT Background: Despite the increased risk for psychopathology in individuals with neurogenetic syndromes, very few psychopharmacology trials have been conducted...

Early Maladaptive Schemas as Core Therapeutic Targets in Eating Disorders and Obesity: A Schema Therapy-Informed Network Analysis

by jlohrconsulting | Sep 22, 2025 | Uncategorized

Clin Psychol Psychother. 2025 Sep-Oct;32(5):e70153. doi: 10.1002/cpp.70153. ABSTRACT Early maladaptive schemas (EMSs) are stable cognitive-emotional patterns central to the psychopathology of eating disorders (EDs) and obesity. This study used a schema...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments